DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story

Forward Printable StoryPrint Comment

 

More HCB News

$115 million settlement of Anthem data breach lawsuit Funds will include credit monitoring for impacted individuals

Gadolinium retention may be more widespread than previously thought Why that is remains to be understood

PET/CT, PET/MR and PET Product Showcase A quick look at all the leading modalities in the market

Philips gets FDA nod to market IntelliSpace Portal 9.0 and new applications Helps quantify and quickly diagnose conditions

This microscope could spare women repeat breast cancer surgeries Light-sheet microscope can scan excised breast tissue for cancer cells in 30 minutes

Solutions for mitigating health care investigation complexities and risks Shifting from reactive to proactive to reduce breaches

Sanford Health, Mid Dakota merger heads to court Would create a group with at least a 75 percent share of physician services

How fast will the U.S. market get access to Gallium-68? The nuclear medicine world is preparing for the introduction of Ga-68 tracers

German researchers find sweet alternative to conventional MR contrast agents Imaging with glucose using 7T MR scanner

Supplemental breast MR superior to ultrasound for screening breast cancer survivors But what about cost-effectiveness?

Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND

Press releases may be edited for formatting or style
Newly Improved Peripheral IV Catheter Is Blood-Drawable, Power-Injectable, and Can Deliver Therapy for Entire Length of Stay

SAN DIEGO -- Access Scientific, Inc. announced it has received FDA 510(k) clearance for the 4Fr Nanopuncture™ POWERWAND®. The unique peripheral IV catheter (technically a midline at 3.1 inches) is lighter and designed to provide smoother handling and even greater ease of insertion.

Story Continues Below Advertisement

WHERE THERE IS SYNERGY, THERE IS STRENGTH

The Conserus™ suite of intelligent, flexible and vendor-neutral imaging solutions can help you connect your staff and existing systems across your entire enterprise. Because stronger connections deliver stronger outcomes. Click link to schedule a demo>>>



The 4Fr Nanopuncture POWERWAND is, like the previously FDA-cleared 5Fr version, a power-injectable, peripheral IV catheter that is inserted using the proprietary Accelerated Seldinger Technique.

The POWERWAND can be used both for the administration of fluids/medications and for withdrawing blood for diagnostic tests. It is the first and only power-injectable peripheral IV (PIV) catheter capable of delivering continuous IV therapy for the patient's entire length of hospital stay. The device may be left in place for up to 29 days per its FDA clearance. It is also designed to be an integral part of any program to reduce central-line associated bloodstream infections (CLABSI).

The catheter has been well received by hospitals using it. "The 4Fr version gives the vascular access team more options. An extended-dwell catheter that can be placed both in the upper arm with ultrasound, or in the lower arm or forearm without using ultrasound, is the bridge we needed between the peripheral IV and the PICC. Sometimes with vascular access we need as many options as we can get," said Peter Hobday, RN, CCRN, CRNI, Director of the Vascular Access team at Brotman Medical Center, in Culver City, Calif.

The POWERWAND's versatility makes it the first and best choice for many patients, said Steve Bierman, M.D., president and CEO of Access Scientific.

"CDC Guidelines now say that patients whose IV therapy will likely exceed six days should have a midline or, if -- and only if - indicated, a central line," Dr. Bierman said. "Based on recent studies, this means that nearly 30% of hospitalized patients should have a POWERWAND."

In addition to allowing consistent blood draws, the catheter has a flow rate of 130 mL per minute -- making it by far the fastest-flowing peripheral line of its size. "This rapid flow rate capability translates into lives saved in the emergency department, OR and ICU," said Dr. Bierman.

The POWERWAND has several notable safety features:

* Alternative to central lines. Because it is not a central line, the catheter does not carry the same high risk of potentially fatal bloodstream infections. Midline catheters such as the 4Fr Nanopuncture POWERWAND have the lowest published bloodstream infection rate of all inpatient vascular access devices.
  Pages: 1 - 2 >>

Related:


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED